Menu
Back to Journals » Degenerative Neurological and Neuromuscular Disease
Degenerative Neurological and Neuromuscular Disease
ISSN: 1179-9900
- View all (117)
- Volume 13, 2023 (3)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Journal Articles:
- 117 records -
Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
Jakimovski D, Wicks TR, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R
Degenerative Neurological and Neuromuscular Disease 2023, 13:21-32
Published Date: 1 February 2023
Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report
Javier-Ormazábal A, Herrero P, González-Platas M
Degenerative Neurological and Neuromuscular Disease 2023, 13:15-20
Published Date: 27 January 2023
Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far
Sivagurunathan N, Gnanasekaran Priyadharshini, Calivarathan L
Degenerative Neurological and Neuromuscular Disease 2023, 13:1-13
Published Date: 26 January 2023
Forelimb Resistance Exercise Protects Against Neuromuscular Junction Denervation in the SOD1-G93A Rat Model of ALS
Nishimune H, Stanford KG, Chen J, Odum JD, Rorie AD, Rogers RS, Wheatley JL, Geiger PC, Stanford JA
Degenerative Neurological and Neuromuscular Disease 2022, 12:145-155
Published Date: 22 November 2022
Sex Differences in Stroke Risk Factors, Clinical Profiles, and In-Hospital Outcomes Among Stroke Patients Admitted to the Medical Ward of Dessie Comprehensive Specialized Hospital, Northeast Ethiopia
Abdu H, Seyoum G
Degenerative Neurological and Neuromuscular Disease 2022, 12:133-144
Published Date: 21 October 2022
No Vitamin D Deficiency in Patients with Parkinson’s Disease
Kuhn W, Karp G, Müller T
Degenerative Neurological and Neuromuscular Disease 2022, 12:127-131
Published Date: 26 September 2022
The Wahls Behavior Change Model for Complex Chronic Diseases: A Clinician’s Guide
Elliott-Wherry AN, Lee JE, Pearlman AM, Wahls TL
Degenerative Neurological and Neuromuscular Disease 2022, 12:111-125
Published Date: 9 September 2022
Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
Isaacson SH, Betté S, Pahwa R
Degenerative Neurological and Neuromuscular Disease 2022, 12:97-109
Published Date: 23 July 2022
Mechanisms of Action of Semen Ziziphi spinosae in the Treatment of Tourette Syndrome
Fan F, Han F, Hao L
Degenerative Neurological and Neuromuscular Disease 2022, 12:85-96
Published Date: 15 July 2022
Effectiveness of Respiratory Muscle Training on Respiratory Muscle Strength, Pulmonary Function, and Respiratory Complications in Stroke Survivors: A Systematic Review of Randomized Controlled Trials
Deme S, Lamba D, Alamer A, Melese H, Ayhualem S, Imeru D, Abebe T
Degenerative Neurological and Neuromuscular Disease 2022, 12:75-84
Published Date: 5 April 2022
Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data
Ruggieri S, Quartuccio ME, Prosperini L
Degenerative Neurological and Neuromuscular Disease 2022, 12:61-73
Published Date: 22 March 2022
Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A
Degenerative Neurological and Neuromuscular Disease 2022, 12:31-59
Published Date: 7 March 2022
Invasive Physiotherapy as a Treatment of Spasticity: A Systematic Review
Javier-Ormazábal A, González-Platas M, González-Sierra E, González-Sierra M
Degenerative Neurological and Neuromuscular Disease 2022, 12:23-29
Published Date: 3 March 2022
Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy
Villaverde-González R
Degenerative Neurological and Neuromuscular Disease 2022, 12:1-21
Published Date: 5 January 2022
The Assessment of Major Histocompatibility Complex (MHC) Class-I Expression in Different Neuromuscular Diseases
Kurdi M, Alshareef A, Bamaga AK, Fadel ZT, Alrawaili MS, Hakamy S, Mohamed F, Abuzinadah AR, Addas BM, Butt NS
Degenerative Neurological and Neuromuscular Disease 2021, 11:61-68
Published Date: 30 December 2021
Effect of Ankle Joint Mobilization with Movement on Range of Motion, Balance and Gait Function in Chronic Stroke Survivors: Systematic Review of Randomized Controlled Trials
Alamer A, Melese H, Getie K, Deme S, Tsega M, Ayhualem S, Birhanie G, Abich Y, Yitayeh Gelaw A
Degenerative Neurological and Neuromuscular Disease 2021, 11:51-60
Published Date: 1 September 2021
RANTES/CCL5 Signaling from Jawbone Cavitations to Epistemology of Multiple Sclerosis – Research and Case Studies
Lechner J, von Baehr V, Schick F
Degenerative Neurological and Neuromuscular Disease 2021, 11:41-50
Published Date: 5 July 2021
Clinical Utility of Opicapone in the Management of Parkinson’s Disease: A Short Review on Emerging Data and Place in Therapy
Azevedo Kauppila L, Pimenta Silva D, Ferreira JJ
Degenerative Neurological and Neuromuscular Disease 2021, 11:29-40
Published Date: 11 May 2021
Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer’s Disease
Labban S, Alshehri FS, Kurdi M, Alatawi Y, Alghamdi BS
Degenerative Neurological and Neuromuscular Disease 2021, 11:15-27
Published Date: 6 May 2021
Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia
Alzobaidi N, Quasimi H, Emad NA, Alhalmi A, Naqvi M
Degenerative Neurological and Neuromuscular Disease 2021, 11:1-14
Published Date: 12 April 2021
Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
Jędrzejowska M
Degenerative Neurological and Neuromuscular Disease 2020, 10:39-47
Published Date: 15 December 2020
Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy
Goldschmidt CH, Hua LH
Degenerative Neurological and Neuromuscular Disease 2020, 10:29-38
Published Date: 26 June 2020
Dysphagia In Multiple Sclerosis Patients: Diagnostic And Evaluation Strategies
Ansari NN, Tarameshlu M, Ghelichi L
Degenerative Neurological and Neuromuscular Disease 2020, 10:15-28
Published Date: 26 March 2020
Prostaglandins as the Agents That Modulate the Course of Brain Disorders
Famitafreshi H, Karimian M
Degenerative Neurological and Neuromuscular Disease 2020, 10:1-13
Published Date: 16 January 2020
Alzheimer’s Disease – Why We Need Early Diagnosis
Rasmussen J, Langerman H
Degenerative Neurological and Neuromuscular Disease 2019, 9:123-130
Published Date: 24 December 2019
Progressive Multifocal Leukoencephalopathy: Current Insights
Kartau M, Sipilä JOT, Auvinen E, Palomäki M, Verkkoniemi-Ahola A
Degenerative Neurological and Neuromuscular Disease 2019, 9:109-121
Published Date: 2 December 2019
Orphan Drugs In Development For The Treatment Of Friedreich’s Ataxia: Focus On Omaveloxolone
Ghanekar SD, Miller WW, Meyer CJ, Fenelon KJ, Lacdao A, Zesiewicz TA
Degenerative Neurological and Neuromuscular Disease 2019, 9:103-107
Published Date: 15 October 2019
Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis
Barnes SL, Simon NG
Degenerative Neurological and Neuromuscular Disease 2019, 9:89-102
Published Date: 16 July 2019
Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease
Lilli NL, Révy D, Robelet S, Lejeune B
Degenerative Neurological and Neuromuscular Disease 2019, 9:79-88
Published Date: 8 July 2019
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials
Costello J, Njue A, Lyall M, Heyes A, Mahler N, Philbin M, Nazareth T
Degenerative Neurological and Neuromuscular Disease 2019, 9:55-78
Published Date: 1 July 2019
Comorbidities in multiple sclerosis—a plea for interdisciplinary collaboration to improve the quality of life of MS patients
Goischke HK
Degenerative Neurological and Neuromuscular Disease 2019, 9:39-53
Published Date: 13 June 2019
Lambert-Eaton Myasthenic syndrome: early diagnosis is key
Ivanovski T, Miralles F
Degenerative Neurological and Neuromuscular Disease 2019, 9:27-37
Published Date: 13 May 2019
Sialorrhea in patients with ALS: current treatment options
Garuti G, Rao F, Ribuffo V, Sansone VA
Degenerative Neurological and Neuromuscular Disease 2019, 9:19-26
Published Date: 20 March 2019
The effects of huntingtin-lowering: what do we know so far?
Kaemmerer WF, Grondin RC
Degenerative Neurological and Neuromuscular Disease 2019, 9:3-17
Published Date: 8 March 2019
Editorial announcing PubMed indexing of Degenerative Neurological and Neuromuscular Disease
Müller T
Degenerative Neurological and Neuromuscular Disease 2019, 9:1-2
Published Date: 27 December 2018
Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies
Preziosi G, Gordon-Dixon A, Emmanuel A
Degenerative Neurological and Neuromuscular Disease 2018, 8:79-90
Published Date: 6 December 2018
Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy – Phase I–II
Dai A, Baspinar O, Yeşilyurt A, Sun E, İnci Aydemir C, Öztel ON, Capkan DU, Pinarli F, Agar A, Karaöz E
Degenerative Neurological and Neuromuscular Disease 2018, 8:63-77
Published Date: 26 October 2018
Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives
Fiorentino G, Annunziata A, Gaeta AM, Lanza M, Esquinas A
Degenerative Neurological and Neuromuscular Disease 2018, 8:55-61
Published Date: 4 September 2018
Physical therapy for individuals with amyotrophic lateral sclerosis: current insights
Dal Bello-Haas V
Degenerative Neurological and Neuromuscular Disease 2018, 8:45-54
Published Date: 16 July 2018
Cladribine tablets’ potential role as a key example of selective immune reconstitution therapy in multiple sclerosis
Boyko AN, Boyko OV
Degenerative Neurological and Neuromuscular Disease 2018, 8:35-44
Published Date: 3 May 2018
Spotlight on postural control in patients with multiple sclerosis
Prosperini L, Castelli L
Degenerative Neurological and Neuromuscular Disease 2018, 8:25-34
Published Date: 3 April 2018
Employment of patients with multiple sclerosis: the influence of psychosocial-structural coping and context
Vijayasingham L, Mairami FF
Degenerative Neurological and Neuromuscular Disease 2018, 8:15-24
Published Date: 26 March 2018
Biomarkers of Duchenne muscular dystrophy: current findings
Al-Khalili Szigyarto C, Spitali P
Degenerative Neurological and Neuromuscular Disease 2018, 8:1-13
Published Date: 25 January 2018
Erythrocyte membrane in the evaluation of neurodegenerative disorders
Sadanand A, Janardhanan A, Sankaradoss A, Vanisree AJ, Arulnambi T, Bhanu K
Degenerative Neurological and Neuromuscular Disease 2017, 7:127-134
Published Date: 17 October 2017
Current concepts in multiple sclerosis therapy
Sedal L, Winkel A, Laing J, Law LY, McDonald E
Degenerative Neurological and Neuromuscular Disease 2017, 7:109-125
Published Date: 28 September 2017
Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions
Ngo ST, Mi JD, Henderson RD, McCombe PA, Steyn FJ
Degenerative Neurological and Neuromuscular Disease 2017, 7:95-108
Published Date: 25 July 2017
Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study
Bisht B, Darling WG, White EC, White KA, Shivapour ET, Zimmerman MB, Wahls TL
Degenerative Neurological and Neuromuscular Disease 2017, 7:79-93
Published Date: 26 June 2017
Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases
Umemoto G, Furuya H, Tsuboi Y, Fujioka S, Arahata H, Sugahara M, Sakai M
Degenerative Neurological and Neuromuscular Disease 2017, 7:71-78
Published Date: 30 May 2017
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
Hinchcliffe M, Smith A
Degenerative Neurological and Neuromuscular Disease 2017, 7:61-70
Published Date: 29 May 2017
Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a
Furber KL, Van Agten M, Evans C, Haddadi A, Doucette JR, Nazarali AJ
Degenerative Neurological and Neuromuscular Disease 2017, 7:47-60
Published Date: 24 March 2017